China National Accord Medicines Corp Ltd Class B 200028
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 14.90
- Day Range
- HKD 14.72–14.94
- 52-Week Range
- HKD 12.25–15.68
- Bid/Ask
- HKD 14.79 / HKD 14.83
- Market Cap
- HKD 8.25 Bil
- Volume/Avg
- 151,220 / 210,184
Key Statistics
- Price/Earnings (Normalized)
- 4.97
- Price/Sales
- 0.10
- Dividend Yield (Trailing)
- 6.06%
- Dividend Yield (Forward)
- —
- Total Yield
- 6.06%
Company Profile
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Value
- Total Number of Employees
- 39,449
- Website
- http://www.szaccord.com.cn
Comparables
Valuation
|
Metric
|
200028
|
002462
|
600285
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.97 | 13.53 | 24.16 |
Price/Book Value | 0.42 | 0.77 | 4.85 |
Price/Sales | 0.10 | 0.11 | 4.14 |
Price/Cash Flow | 3.62 | 2.83 | 18.28 |
Price/Earnings
200028
002462
600285
Financial Strength
|
Metric
|
200028
|
002462
|
600285
|
|---|---|---|---|
Quick Ratio | 1.12 | 1.17 | 1.14 |
Current Ratio | 1.44 | 1.51 | 1.49 |
Interest Coverage | 10.70 | — | — |
Quick Ratio
200028
002462
600285
Profitability
|
Metric
|
200028
|
002462
|
600285
|
|---|---|---|---|
Return on Assets (Normalized) | 3.13% | 1.47% | 12.44% |
Return on Equity (Normalized) | 9.09% | 5.80% | 21.12% |
Return on Invested Capital (Normalized) | 6.32% | 2.46% | 19.26% |
Return on Assets
200028
002462
600285
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Tgwyvyzk | Vspvxty | $76.7 Bil | |||
| Cencora Inc
COR
| Nwlkjvvz | Tpfrg | $45.8 Bil | |||
| Cardinal Health Inc
CAH
| Wjfhhngb | Vcydm | $24.4 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Cxlyx | $8.8 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Dtybyx | $8.8 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Znmjh | $8.6 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Nyklhgc | $8.6 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Ycvffd | $8.4 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Jtrbc | $3.2 Bil | |||
| Medipal Holdings Corp
MEPDF
| — | Plqt | $3.2 Bil |